Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001037389-24-000096·IRONWOOD PHARMACEUTICALS INC
Schedule 13G ownership disclosure
Ironwood Pharmaceuticals Inc
Class A common stock, $0.001 par value per share · CUSIP: 46333X108
Event date: 2024-05-15
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Renaissance Technologies LLC
Shares: 8,597,198 · Class: 5.37%
- Renaissance Technologies Holdings Corporation
Shares: 8,597,198 · Class: 5.37%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001037389-24-000096
- Form type
- SCHEDULE 13G
- Filer
- IRONWOOD PHARMACEUTICALS INC
- CIK
- CIK 1446847
- Filed
- Nov 13, 2024
- Reporting period
- May 15, 2024
- Description
- Schedule 13G beneficial ownership